adults 65 years of age and older ask a doctor adults and children 12 to 64 years of age take 1 tablet (5 mg) once daily in the evening do not take more than 1 tablet (5 mg) in 24 hours ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6 to 11 years of age take ½ tablet (2.5 mg) once daily in the evening do not take more than ½ ta...
Levocetirizine dihydrochloride USP 5 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other respiratory allergies:
• runny nose
• sneezing
• itchy, watery eyes
• itching of the nose or throat
• if you have kidney disease
• if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine
• you have trouble urinating or emptying your bladder
• an allergic reaction to this product occurs. Seek medical help right away.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults 65 years of age and older
|
|
| adults and children 12 to 64 years of age
|
|
| children 6 to 11 years of age
|
|
| children under 6 years of age
|
|
| consumers with kidney disease
|
|
• store between 20° and 25°C (68° and 77°F)
• safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
• safety sealed: do not use if carton was opened or if individual blister unit is open or torn
colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide.
call 1-844-384-3723.
Distributed by:
Safrel Pharmaceuticals, LLC
Bridgewater, NJ 08807
Levocetirizine Dihydrochloride Tablets USP 5 mg-180 Tablets
Compare to XYZAL
® Allergy 24HR Active Ingredient*
Allergy Relief
Levocetirizine Dihydrochloride
Tablets, USP
5 mg
Antihistamine
24 HOUR Relief of
Original Prescription Strength
180 TABLETS
| Class | Version | Type | Effective |
|---|---|---|---|
| LEVOCETIRIZINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 36cf9111-9cc4-8f59-a74c-0c1cfbd4a760 | Product name | 7 | 20190702 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71309-112-18 | Levocetirizine Dihydrochloride | 180 in 1 BOTTLE | TABLET, FILM COATED | 180 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71309-112 | 71309-112-18 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
| LEVOCETIRIZINE DIHYDROCHLORIDE | SOD6A38AGA | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f4ab9fca-5fb1-518a-e053-2a95a90a3420 | f4aba1d6-2516-3b8a-e053-2995a90a5626 | 2023-02-14 | f4ab9fca-5fb1-518a-e053-2a95a90a3420 f4aba1d6-2516-3b8a-e053-2995a90a5626 |
Adverse event summaries are temporarily unavailable. Other product information remains available.
